{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T03:41:14Z","timestamp":1792381274357,"version":"4.4.0"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"am","delay-in-days":221,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.mehy.2020.109959","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T21:28:55Z","timestamp":1591392535000},"page":"109959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2?"],"prefix":"10.1016","volume":"144","author":[{"given":"Dan","family":"Lipsker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.109959_b0005","doi-asserted-by":"crossref","DOI":"10.1111\/pde.14215","article-title":"Chilblains in children in the setting of COVID-19 pandemic","author":"Andina","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.mehy.2020.109959_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2020.04.161","article-title":"Chilblains are a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France","author":"de Masson","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mehy.2020.109959_b0015","doi-asserted-by":"crossref","DOI":"10.1111\/pde.14210","article-title":"Chilblains-like lesions in children following suspected Covid-19 infection","author":"Colonna","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.mehy.2020.109959_b0020","doi-asserted-by":"crossref","DOI":"10.1111\/ced.14275","article-title":"Chilblain-like lesions: a case series of 41 patients during the COVID-19 pandemic","author":"L\u00f3pez-Robles","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.mehy.2020.109959_b0025","article-title":"Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak","author":"Fernandez-Nieto","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.mehy.2020.109959_b0030","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1084\/jem.20161596","article-title":"Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview","volume":"213","author":"Rodero","year":"2016","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.mehy.2020.109959_b0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12969-016-0094-4","article-title":"Type I interferonopathies in pediatric rheumatology","volume":"14","author":"Volpi","year":"2016","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720313414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720313414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:22:30Z","timestamp":1759692150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720313414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":7,"alternative-id":["S0306987720313414"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109959","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109959"}}